149 related articles for article (PubMed ID: 27754415)
1. Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer.
Verde Z; Santiago C; Chicharro LM; Reinoso-Barbero L; Tejerina A; Bandrés F; Gómez-Gallego F
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754415
[TBL] [Abstract][Full Text] [Related]
2. APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.
Osawa K; Miyaishi A; Uchino K; Osawa Y; Inoue N; Nakarai C; Tsutou A; Kido Y; Yoshimura M; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2010; 11(5):1181-6. PubMed ID: 21198260
[TBL] [Abstract][Full Text] [Related]
3. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms and the effect of cigarette smoking in the comet assay.
Hoffmann H; Isner C; Högel J; Speit G
Mutagenesis; 2005 Sep; 20(5):359-64. PubMed ID: 16037119
[TBL] [Abstract][Full Text] [Related]
12. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
Cotterchio M; Mirea L; Ozcelik H; Kreiger N
Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
16. [Association of the nicotine and cigarette smoke toxicants metabolic (CHRNA3/5, CYP2A6, NQO1) and DNA repair genes (XRCC1, XRCC3, XPC, XPA) with chronic obstructive pulmonary disease].
Korytina GF; Akhmadishina LZ; Kochetova OV; Burdiuk IuV; Aznabaeva IuG; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2014; 48(6):939-51. PubMed ID: 25845234
[TBL] [Abstract][Full Text] [Related]
17. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
[TBL] [Abstract][Full Text] [Related]
18. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.
Affatato AA; Wolfe KJ; Lopez MS; Hallberg C; Ammenheuser MM; Abdel-Rahman SZ
Environ Mol Mutagen; 2004; 44(1):65-73. PubMed ID: 15199548
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
